124.88
9.21 (7.96%)
| Previous Close | 115.67 |
| Open | 113.18 |
| Volume | 2,417,823 |
| Avg. Volume (3M) | 1,786,800 |
| Market Cap | 7,830,902,784 |
| Price / Sales | 16.36 |
| Price / Book | 16.27 |
| 52 Weeks Range |
| Profit Margin | -54.98% |
| Operating Margin (TTM) | -44.79% |
| Diluted EPS (TTM) | -3.25 |
| Quarterly Revenue Growth (YOY) | 23.20% |
| Total Debt/Equity (MRQ) | 18.25% |
| Current Ratio (MRQ) | 4.51 |
| Operating Cash Flow (TTM) | -56.11 M |
| Levered Free Cash Flow (TTM) | -16.89 M |
| Return on Assets (TTM) | -15.04% |
| Return on Equity (TTM) | -38.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Twist Bioscience Corporation | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -4.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.75 |
|
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Core |
| % Held by Insiders | 1.98% |
| % Held by Institutions | 115.15% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CHO DENNIS | - | 115.01 | -14,205 | -1,633,717 |
| Aggregate Net Quantity | -14,205 | |||
| Aggregate Net Value ($) | -1,633,717 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 115.01 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| CHO DENNIS | Officer | 05 Aug 2026 | Automatic sell (-) | 14,205 | 115.01 | 1,633,717 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |